NASDAQ | DRNA

$3.23 - 0.14 (-4.154%)

3 month stock price graph

4:00 PM ET on Jun 28, 2017 Pricing delayed 20 minutes

Investors & Media

Analyst Coverage

Dicerna Pharmaceuticals is covered by the following analysts.

Analyst Coverage
Firm Analyst
Chardan
Madhu Kumar, PhD
Cowen
Ritu Baral
H.C. Wainwright & Co.
Shaunak Deepak
Jefferies
Eun Yang
Leerink Partners
Paul Matteis
Stifel
Steve Willey

Please note that any opinions, estimates or forecasts regarding Dicerna Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Dicerna Pharmaceuticals or its management. Dicerna Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.